Table 3. Antimicrobial resistance of Campylobacter fetus strains isolated from patients with and without bacteremia, Nord Franche-Comté Hospital, Trévenans, France, 2000–2021*.
| Antimicrobial tested | All patients, no. (%), n = 33 | Patients with no C. fetus bacteremia, no. (%), n = 12 |
Patients with C. fetus bacteremia, no. (%), n = 21 |
p value |
|---|---|---|---|---|
| Amoxicillin† | 3/28 (10.7) | 1/8 (12) | 2/20 (10) | 0.3 |
| Amoxicillin–clavulanic acid | 0/28 | 0/8 | 0/20 | |
| Imipenem | 0/28 | 0/8 | 0/20 | |
| Gentamicin | 0/27 | 0/8 | 0/19 | |
| Azithromycin | 2/29 (6.9) | 0/9 | 2/20 (10) | >0.9 |
| Fluoroquinolones: ofloxacin and ciprofloxacin‡ | 8/27 (30) | 2/9 (22) | 6/18 (33) | 0.7 |
| Doxycycline | 7/29 (24) | 1/9 (11) | 6/20 (30) | 0.4 |
*Values are no. resistant/no. tested (%) except as indicated. Blank cells for p values indicate no p value was calculated. †Susceptibility to amoxicillin was intermediate (susceptible with high doses) for 2 strains. ‡Susceptibility to ofloxacin and ciprofloxacin was the same for all strains.